Insider Transactions in Q1 2023 at Baxter International Inc (BAX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 20
2023
|
Brian Stevens SVP, CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
161
-0.49%
|
$6,118
$38.19 P/Share
|
|
Mar 20
2023
|
Albert P L Stroucken Director |
SELL
Open market or private sale
|
Direct |
3,930
-9.64%
|
$145,410
$37.52 P/Share
|
|
Mar 20
2023
|
Albert P L Stroucken Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,930
+8.79%
|
$141,480
$36.93 P/Share
|
|
Mar 20
2023
|
Heather Knight EVP, Group Pres, Med Products |
SELL
Payment of exercise price or tax liability
|
Direct |
212
-0.4%
|
$8,056
$38.19 P/Share
|
|
Mar 20
2023
|
Reaz Rasul EVP,Group Pres,Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
151
-0.56%
|
$5,738
$38.19 P/Share
|
|
Mar 03
2023
|
Heather Knight EVP, Group Pres, Med Products |
SELL
Payment of exercise price or tax liability
|
Direct |
220
-0.41%
|
$8,580
$39.94 P/Share
|
|
Mar 03
2023
|
Reaz Rasul EVP,Group Pres,Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
148
-0.55%
|
$5,772
$39.94 P/Share
|
|
Mar 03
2023
|
Brian Stevens SVP, CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-0.55%
|
$7,176
$39.94 P/Share
|
|
Mar 02
2023
|
Jose E Almeida Chairman, CEO, President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,642
-1.12%
|
$181,038
$39.62 P/Share
|
|
Mar 02
2023
|
James W Borzi EVP,Chief Supply Chain Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
474
-2.31%
|
$18,486
$39.62 P/Share
|
|
Mar 02
2023
|
Cristiano Franzi SVP, President, EMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
146
-0.14%
|
$5,694
$39.62 P/Share
|
|
Mar 02
2023
|
Heather Knight EVP, Group Pres, Med Products |
SELL
Payment of exercise price or tax liability
|
Direct |
1,067
-1.95%
|
$41,613
$39.62 P/Share
|
|
Mar 02
2023
|
Jacqueline Kunzler SVP, Chief Quality Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
271
-1.18%
|
$10,569
$39.62 P/Share
|
|
Mar 02
2023
|
Jeanne K Mason EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
460
-0.33%
|
$17,940
$39.62 P/Share
|
|
Mar 02
2023
|
Reaz Rasul EVP,Group Pres,Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
416
-1.51%
|
$16,224
$39.62 P/Share
|
|
Mar 02
2023
|
James Saccaro EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,061
-0.59%
|
$41,379
$39.62 P/Share
|
|
Mar 02
2023
|
Brian Stevens SVP, CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
418
-1.24%
|
$16,302
$39.62 P/Share
|
|
Mar 01
2023
|
James Saccaro EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,217
+11.04%
|
-
|
|
Mar 01
2023
|
Brian Stevens SVP, CAO & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
6,788
+16.78%
|
-
|
|
Mar 01
2023
|
Heather Knight EVP, Group Pres, Med Products |
BUY
Grant, award, or other acquisition
|
Direct |
21,600
+28.34%
|
-
|
|
Mar 01
2023
|
Reaz Rasul EVP,Group Pres,Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
15,428
+35.95%
|
-
|
|
Mar 01
2023
|
Alok Sonig EVP,Group President, Pharma |
BUY
Grant, award, or other acquisition
|
Direct |
15,428
+31.71%
|
-
|
|
Mar 01
2023
|
Jose E Almeida Chairman, CEO, President |
BUY
Grant, award, or other acquisition
|
Direct |
67,884
+14.11%
|
-
|
|
Mar 01
2023
|
James W Borzi EVP,Chief Supply Chain Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,640
+29.6%
|
-
|
|
Mar 01
2023
|
Steven Flynn SVP, President, APAC |
BUY
Grant, award, or other acquisition
|
Direct |
18,514
+26.6%
|
-
|
|
Mar 01
2023
|
Cristiano Franzi SVP, President, EMEA |
BUY
Grant, award, or other acquisition
|
Direct |
40,113
+18.01%
|
-
|
|
Mar 01
2023
|
Jacqueline Kunzler SVP, Chief Quality Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,171
+21.23%
|
-
|
|
Mar 01
2023
|
Jeanne K Mason EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,491
+7.0%
|
-
|
|
Mar 01
2023
|
David S. Rosenbloom EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
13,885
+19.84%
|
-
|
|
Feb 21
2023
|
Jacqueline Kunzler SVP, Chief Quality Officer |
SELL
Open market or private sale
|
Direct |
3,813
-18.57%
|
$152,520
$40.5 P/Share
|
|
Feb 21
2023
|
Jacqueline Kunzler SVP, Chief Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,163
+16.85%
|
$154,031
$37.82 P/Share
|
|
Feb 13
2023
|
James Saccaro EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,059
-0.67%
|
$42,360
$40.5 P/Share
|
|
Feb 13
2023
|
James Saccaro EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,362
+2.09%
|
-
|
|
Feb 13
2023
|
Jacqueline Kunzler SVP, Chief Quality Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
715
-4.18%
|
$28,600
$40.5 P/Share
|
|
Feb 13
2023
|
Jacqueline Kunzler SVP, Chief Quality Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,068
+10.79%
|
-
|
|
Feb 13
2023
|
Jeanne K Mason EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,061
-0.82%
|
$42,440
$40.5 P/Share
|
|
Feb 13
2023
|
Jeanne K Mason EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,621
+2.71%
|
-
|
|
Feb 13
2023
|
Brian Stevens SVP, CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
224
-0.83%
|
$8,960
$40.5 P/Share
|
|
Feb 13
2023
|
Brian Stevens SVP, CAO & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
646
+2.33%
|
-
|
|
Feb 13
2023
|
Jose E Almeida Chairman, CEO, President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,053
-2.83%
|
$402,120
$40.5 P/Share
|
|
Feb 13
2023
|
Jose E Almeida Chairman, CEO, President |
BUY
Grant, award, or other acquisition
|
Direct |
31,044
+8.04%
|
-
|
|
Feb 13
2023
|
Steven Flynn SVP, President, APAC |
BUY
Grant, award, or other acquisition
|
Direct |
516
+3.96%
|
-
|
|
Feb 13
2023
|
Cristiano Franzi SVP, President, EMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
275
-0.44%
|
$11,000
$40.5 P/Share
|
|
Feb 13
2023
|
Cristiano Franzi SVP, President, EMEA |
BUY
Grant, award, or other acquisition
|
Direct |
5,174
+7.65%
|
-
|
|
Jan 17
2023
|
Jeanne K Mason EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
59,477
-32.03%
|
$2,616,988
$44.7 P/Share
|
|
Jan 17
2023
|
Jeanne K Mason EVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
59,477
+24.26%
|
$2,200,649
$37.82 P/Share
|